- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: MALT Type
Total 65144 results
-
University of Illinois at Urbana-ChampaignRenal Research InstituteCompletedBone Diseases, Endocrine | Nutritional and Metabolic DiseasesUnited States
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany, Austria
-
Centre Hospitalier Universitaire de NiceUnknownMalignant Melanoma Stage III | Malignant Melanoma Stage IV
-
Maastricht University Medical CenterTop Institute Food and NutritionCompleted
-
University of UlmTerminated
-
Beneo-InstituteCompletedInfectious Disease | Diet Modification | Children, Only
-
University of UlmTerminatedAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Germany
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompletedLymphoma of the Mucosa Associated Lymphoid Tissue (MALT)Austria
-
National Taiwan University HospitalUnknown
-
Polish Lymphoma Research GroupCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Small Lymphocytic LymphomaPoland
-
Aarhus University HospitalRigshospitalet, Denmark; University of Copenhagen; University of California,... and other collaboratorsCompletedCardiovascular Disease | Metabolic Syndrome | Type 2 Diabetes | Abdominal ObesityDenmark
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Medical University of WarsawUnknownDiabetes Mellitus, Type 1
-
Eisai Co., Ltd.CompletedGastric Low-grade MALT Lymphoma With Helicobacter Pylori PositiveJapan
-
Qingdao Zhixin Health Technology Co., Ltd.H & J CRO International, Inc.UnknownDiabetes Mellitus, Type 2China
-
AGO Study GroupMerck Sharp & Dohme LLCCompletedCarcinosarcoma | Leiomyosarcoma | Mesenchymal TumorGermany
-
Beth ChristianGilead SciencesCompleted
-
National Taiwan University HospitalUnknownMucosa-Associated Lymphoid Tissue LymphomaTaiwan
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedLymphoma, Non-Hodgkin | MALT LymphomaUnited States
-
National Health Research Institutes, TaiwanCompleted
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; China Medical University Hospital; Chang... and other collaboratorsCompletedGastric MALT LymphomaTaiwan
-
Genzyme, a Sanofi CompanyTerminatedGlycogenosis 2 | Glycogen Storage Disease Type II (GSD II) | Acid Maltase Deficiency | Pompe Disease (Infantile-Onset)United States, Taiwan, Germany
-
Hospices Civils de LyonCompleted
-
Medical University of ViennaCompleted
-
ClinAssessSanofi; Merck Sharp & Dohme LLCCompletedSquamous Cell Carcinoma of the Hypopharynx | Larynx CarcinomaGermany, Austria
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, France, Netherlands
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2United States, France, Netherlands
-
Columbia UniversityWithdrawnGlycogen Storage Disease Type IIUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedS0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver DysfunctionLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
P BurnsKarolinska Institutet; Universidad de Murcia; University of Leeds; University of... and other collaboratorsCompleted
-
International Extranodal Lymphoma Study Group (IELSG)TerminatedLymphoma, Mucosa-Associated Lymphoid TissueSwitzerland
-
Bastyr UniversityCompletedDiabetes Mellitus, Type 2United States
-
Genzyme, a Sanofi CompanyCompletedGlycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)United States, Netherlands, United Kingdom, Germany
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); New York UniversityCompletedGastric Cancer | Gastric AdenocarcinomaUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease | Glycogenesis 2 Acid Maltase DeficiencyUnited States, Canada, Australia
-
AGO Study GroupPhilipps University Marburg Medical Center; HSK Reasearch GmbH WiesbadenCompletedPlatinum Refractory Epithelial Ovarian Cancer | Primary Cancer of the Peritoneum | Cancer of the Fallopian TubeGermany
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, France, Germany, Israel, Italy, Netherlands, Taiwan
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2Netherlands
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Glycogenosis 2United States
-
Genzyme, a Sanofi CompanyCompletedGlycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)France
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2France
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II | Glycogenosis 2
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States, Israel, France, United Kingdom